- Home
- PDEX vs NRXP Comparison
PDEX vs NRXP Comparison
Compare PDEX & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDEX | NRXP |
|---|---|---|
| Founded | 1978 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.4M | 181.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | PDEX | NRXP |
|---|---|---|
| Price | $55.88 | $4.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $56.00 | $38.25 |
| AVG Volume (30 Days) | 81.6K | ★ 910.8K |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 345.00 | N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | ★ $66,593,000.00 | N/A |
| Revenue This Year | $7.22 | $2,547.84 |
| Revenue Next Year | N/A | $1,591.73 |
| P/E Ratio | $16.72 | ★ N/A |
| Revenue Growth | ★ 23.68 | N/A |
| 52 Week Low | $23.52 | $1.65 |
| 52 Week High | $68.99 | $5.06 |
Technical Indicators
Market Signals| Indicator | PDEX | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 59.55 |
| Support Level | $55.29 | $1.83 |
| Resistance Level | $61.62 | $4.59 |
| Average True Range (ATR) | 3.53 | 0.28 |
| MACD | -0.67 | 0.01 |
| Stochastic Oscillator | 14.67 | 70.89 |
Price Performance
Historical ComparisonAbout PDEX Pro-Dex Inc.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.